Status:
COMPLETED
Effects of Food Advanced Glycation Endproducts on Vascular Function in Diabetes
Lead Sponsor:
Profil Institut für Stoffwechselforschung GmbH
Collaborating Sponsors:
Heart and Diabetes Center North-Rhine Westfalia
Icahn School of Medicine at Mount Sinai
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
Recent evidence supports detrimental effects of advanced glycation endproducts (AGE) on vascular function (VF). Though, the effect of AGE-modified proteins alone on vascular function remained unknown....
Detailed Description
In a double-blind, controlled, randomized, cross-over manner, 19 subjects with T2DM will receive on 2 different days beverages containing either glycated, heat-treated BLG or non-glycated, heat-treate...
Eligibility Criteria
Inclusion
- Type 2 diabetes mellitus
Exclusion
- Other types of diabetes
- Major cardiovascular complications within 6 months prior to screening
- Major diabetes complications
- Failure to give informed consent
Key Trial Info
Start Date :
June 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT01456026
Start Date
June 1 2009
End Date
May 1 2010
Last Update
October 20 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Heart and Diabetes Center North-Rhine Westfalia
Bad Oeynhausen, North Rhine-Westphalia, Germany, 32545